Papers
11
Total Citations
301
H-Index
9
About
Andreas Rillig is a leading cardiac electrophysiologist whose research has fundamentally advanced the safety and efficacy of catheter ablation for atrial fibrillation (AF). His work centers on robotic navigation systems, comparing their performance to conventional manual techniques, and rigorously investigating procedure-related complications. Dr. Rillig’s major contributions include pioneering studies on the incidence of oesophageal lesions and persistent iatrogenic atrial septal defects following pulmonary vein isolation (PVI) using remote robotic systems, with his landmark 2010 paper on oesophageal temperature monitoring accumulating 62 citations. He also led the “Man and Machine Trial,” a prospective, international noninferiority study that provided critical evidence on robotic versus manual ablation outcomes. His research on silent cerebral lesions after PVI (51 citations) has been instrumental in shaping procedural safety standards. Notably, Dr. Rillig has demonstrated the learning curve for robotic ablation and its benefits in complex anatomies, such as dextrocardia. With multiple highly cited publications and a sustained focus on improving patient outcomes through technological innovation, he remains a key figure in the evolution of AF ablation therapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10